Chronic Lymphocytic Leukemia Registry Study - Multicenter Prospective National Study

Turkish Chronic Lymphocytic Leukemia Study Group Registry - Multicenter Prospective Study

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT03197259

Acronym

CLLTRegistry

Enrollment

1000

Registered

2017-06-23

Start date

2017-01-01

Completion date

2026-08-01

Last updated

2021-03-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Lymphocytic Leukemia, Del(17P)

Keywords

CLL, del(17p)

Brief summary

A prospective, multicenter national observational study for patients diagnosed as chronic lymphocytic leukemia across 25 centers in Turkey

Detailed description

The purpose of this study is to explore the history and real world management of patients diagnosed with CLL, provide insight into the management of CLL, and evaluate the effectiveness of first, second and subsequent therapeutic strategies employed in both the community and academic settings.

Interventions

None listed

Study design

Observational model

OTHER

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Patients diagnosed as CLL * 18 years or older * Able and willing to provide the written informed consent

Exclusion criteria

* Younger than 18 years

Design outcomes

Primary

Measure	Time frame	Description
First line therapy therapy protocol distrubition	36 months	The primary objective is to describe percentage of first line therapy protocols in patients initiated on therapy for CLL in the community and academic setting

Countries

Turkey (Türkiye)

Contacts

Primary ContactFatih Demirkan, Prof

fatihdemirkan@yahoo.com+90 542 515 17 80

Outcome results